Your browser doesn't support javascript.
loading
Keratinocytes sense and eliminate CRISPR DNA through STING/IFN-κ activation and APOBEC3G induction.
Sarkar, Mrinal K; Uppala, Ranjitha; Zeng, Chang; Billi, Allison C; Tsoi, Lam C; Kidder, Austin; Xing, Xianying; Perez White, Bethany E; Shao, Shuai; Plazyo, Olesya; Sirobhushanam, Sirisha; Xing, Enze; Jiang, Yanyun; Gallagher, Katherine A; Voorhees, John J; Kahlenberg, J Michelle; Gudjonsson, Johann E.
Afiliación
  • Sarkar MK; Department of Dermatology, and.
  • Uppala R; Department of Dermatology, and.
  • Zeng C; Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, USA.
  • Billi AC; Department of Dermatology, and.
  • Tsoi LC; Department of Dermatology, and.
  • Kidder A; Department of Dermatology, and.
  • Xing X; Department of Dermatology, and.
  • Perez White BE; Department of Dermatology, and.
  • Shao S; Department of Dermatology, Northwestern University, Chicago, Illinois, USA.
  • Plazyo O; Department of Dermatology, and.
  • Sirobhushanam S; Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi, China.
  • Xing E; Department of Dermatology, and.
  • Jiang Y; Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Gallagher KA; Department of Dermatology, and.
  • Voorhees JJ; Department of Dermatology, and.
  • Kahlenberg JM; Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Gudjonsson JE; Section of Vascular Surgery, Department of Surgery.
J Clin Invest ; 133(9)2023 05 01.
Article en En | MEDLINE | ID: mdl-36928117

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article
...